Premium IOLs in Imperfect Eyes  - Summary - MDSpire

Premium IOLs in Imperfect Eyes 

Kavitha R. Sivaraman, MD, ABO and Dagny Zhu, MD, ABO discuss premium options for patients with corneal pathology and post-refractive corneas.

  • April 11, 2026

  • 6 min

Share

Objective:

Specify the target audience for the guidelines.

Approach:
    Key Findings:
    • Add implications of findings for practice.
    Interpretation:

    Emphasize the importance of individualized assessments.

    Limitations:
    • Expand on potential biases or gaps in content.
    Conclusion:

    Reiterate the importance of ongoing education for surgeons.

Original Source(s)

Premium IOLs in Imperfect Eyes 

  • April 11, 2026

Related Content

Association between social vulnerability index and cataract surgery care in medicare beneficiaries: a retrospective cohort study

New Technologies and Best Practices for In-Office YAG

Nicholas R. Green, OD, MPH, FAAO, presents clinical pearls on YAG Capsulotomy at Optometry's Meeting 2026.

Combined phacoemulsification and angle filtering procedures versus phacoemulsification with clinical outcomes in primary glaucoma coexisting with cataracts: a meta-analysis of randomized controlled trials